Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity

Gene Therapy

Volumn 8, Issue 4, 2001, Pages 282-290

  Palmer, K ^a   Hitt, M ^a   Emtage, P C R ^a   Gyorffy, S ^a   Gauldie, J ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Cancer; Chemokines; Cytokines; Gene therapy; Immunotherapy

Indexed keywords

ALPHA CHEMOKINE; ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; B7 ANTIGEN; BASIC FIBROBLAST GROWTH FACTOR; CD3 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; CHEMOTACTIC FACTOR; CYTOKINE; ETHIDIUM BROMIDE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 12; INTERLEUKIN 4; MATRIGEL; MESSENGER RNA; MONOKINE; PROTEIN P35; PROTEIN P40; VIRUS PROTEIN; VIRUS RNA; VIRUS T ANTIGEN; VIRUS VECTOR;

ADENOVIRUS; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER INHIBITION; CANCER MODEL; CANCER SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FIBROSARCOMA; GENE TRANSFER; IN VIVO STUDY; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR REGRESSION;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD3; BLOTTING, NORTHERN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINES, CXC; COLLAGEN; CYTOTOXICITY TESTS, IMMUNOLOGIC; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE THERAPY; GENETIC VECTORS; INJECTIONS, INTRALESIONAL; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; LAMININ; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PROTEOGLYCANS; T-LYMPHOCYTES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ADENOVIRIDAE; ANIMALIA; DNA VIRUSES; MURINAE; RNA VIRUSES;

EID: 0035085442     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301386     Document Type: Article

References (40)

1. Intratumoral coinjection of adenoviral vectors expressing IL-2 and Il-12 results in enhanced frequency of regression of injected and untreated distal tumors
2. Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of Interleukin-12
3. Interleukin-12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression
4. Cytokines (IFNs, TNF-alpha, IL-2 and IL-12) and animal models of cancer
5. The diversity of T-cell co-stimulation in the induction of antitumor immunity
6. Antitumor and antimetastatic activity of interleukin 12 against murine tumors
7. Interleukin-12: A cytokine at the interface of inflammation and immunity
8. Role of interferon-gamma in mediating the anti-tumor efficacy of interleukin-12
9. γ-Interferon transcriptionally regulates an early-reponse gene containing homology to platelet proteins
10. Human Mig chemokine: Biochemical and functional characterization
11. IP-10, a gamma-interferon-inducible protein related to interleukin-8, lacks neutrophil activating properties
12. Chemokine receptor specific for IP10 and mig: Structure, function, and expression in activated T-lymphocytes
13. α and β chemokines induce NK cell migration and enhance NK cell cytolytic activity via cellular degradation
14. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells
15. Interferon-inducible protein-10 and lymphotactin induce the chemotaxis and mobilization of intracellular calcium in natural killer cells through pertussis toxin-sensitive and -insensitive heterotrimeric G-proteins
16. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo
17. Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases
18. Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo
19. Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivo
20. Mig and IP-10: CXC chemokines that target lymphocytes
21. The CXC chemokines IP-10 and Mig are necessary for IL-12 mediated regression of mouse RENCA tumor
22. The toxicology of interleukin-12: A review
23. Transient gene transfer of non-ELR chemokines to rodent lung induces mononuclear cell accumulation and activation
24. Induction of mammary tumors by expression of polymona middle T oncogene: A transgenic model for metastatic disease
25. Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model
26. Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models
27. Lymphotactin: A cytokine that represents a new class of chemokine
28. Migratory response of human natural killer cells to lymphotactin
29. Human interferon-inducible protein-10 induces mononuclear cell infiltration in mice and promotes the migration of human T lymphocytes into the peripheral tissues and human peripheral blood lymphocytes-SCID mice
30. The central role of CD4+ T cells in the antitumor immune response
31. CCR5 is characteristic of Th1 lymphocytes
32. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
33. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression
34. Inhibition of angiogenesis in vivo by interleukin 12
35. Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis
36. Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10
37. Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis
38. Contribution of the CXC chemokines IP-10 and MIG to the antitumor effects of IL-12
39. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression
40. Apoptosis or necrosis for tumor immunotherapy: What's in a name